CLINICAL TRIAL

EUS enhanced with contrast to evaluate pancreas for Pancreatic Cyst

Recruiting · 18+ · All Sexes · Los Angeles, CA

Contrast EUS of the Pancreas

See full description

About the trial for Pancreatic Cyst

Eligible Conditions
Pancreatic Cyst · Pancreatic Neoplasms · Pancreatitis

Treatment Groups

This trial involves 2 different treatments. EUS Enhanced With Contrast To Evaluate Pancreas is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
EUS enhanced with contrast to evaluate pancreas
OTHER
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

Eligibility

This trial is for patients born any sex aged 18 and older. There are 2 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Patients with unexplained pancreatitis, pancreatic mass(es), or pancreatic cystic lesions (>1cm or worrisome features on imaging) are required to have a biopsy. show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 6 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 6 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether EUS enhanced with contrast to evaluate pancreas will improve 1 primary outcome and 2 secondary outcomes in patients with Pancreatic Cyst. Measurement will happen over the course of 6 months.

The yield of EUS versus contrast EUS to diagnose pancreas cystic lesions, mass lesion, and origin of pancreatitis.
6 MONTHS
The endoscopist will perform conventional EUS and classify the lesion as described below, this will be recorded by the research assistant prior to contrast EUS. Contrast will then be administered and the classification of contrast EUS recorded in real time. The gold standard to calculate the yields of the modality will be on pathology and clinical diagnosis at three and six months. Additionally we will assess whether contrast impacted assessment of size and diagnosis.
Targeting of FINE NEEDLE ASPIRATION (FNA) of pancreas lesions.
6 MONTHS
A) The decision to perform a FINE NEEDLE ASPIRATION of the lesion will be based solely on the standard EUS exam. After making the decision to perform the FNA contrast EUS will be performed. We will assess the degree to whether contrast administration helped to better target the FNA of the chosen lesion
Quantitative Parameters of Pancreas Lesions
6 MONTHS
Quantitative parameters of pancreas mass lesions will be performed by comparing the quantitative parameters post processing of adenocarcinoma, neuroendocrine and other lesion, and chronic pancreatitis. The final diagnosis will be based on pathology and 3 and 6 month follow up. Comparison variables will include time to peak (SECONDS), rise time (SECONDS), mean transit time (SECONDS), and time from peak to one-half (SECONDS).

Who is running the study

Principal Investigator
J. B.
Prof. James Buxbaum, Associate Professor of Clinical Medicine
University of Southern California

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people get pancreatic cyst a year in the United States?

In a 15-year period from 1993 to 2007, the annual incidence of cystic lesions of pancreas in adults was 2.4 per 10,000 inhabitants. Pancreatic cyst was the most common type of cystic pancreas lesion. Further studies are required to define the exact underlying genetics of pancreatic cyst genesis.

Anonymous Patient Answer

Can pancreatic cyst be cured?

When a cyst in the pancreas ruptured with no associated injuries, a cystoperitoneal fistula and peritoneal sepsis, we were able to operate on the cyst. This is one of the few reports that surgical treatment can be applied for treatment of pancreatic cyst. We hypothesize that the surgical treatment can lead to improvement of symptoms and quality of life. But there are still few reports of the treatment for pancreatic cyst.

Anonymous Patient Answer

What are the signs of pancreatic cyst?

Signs of pancreatic cysts include loss of appetite, pain, nausea and vomiting. A palpable abdominal mass is a major presenting sign of pancreatic cysts. A non-enhancing mass on computed tomography (CT) imaging can be a sign of an extra-pancreatic source such as cancer or fluid collection.

Anonymous Patient Answer

What causes pancreatic cyst?

The most common cause of a pancreatic cyst is ductal dilation following chronic pancreatitis. Other causes of pancreatic cyst include pancreatic cancer and intraductal papilloma.

Anonymous Patient Answer

What are common treatments for pancreatic cyst?

A meta-analysis of existing randomized control trial literature was performed. Randomized controlled trials and case reports involving treatments were evaluated to determine the safety and efficacy of each treatment. The best clinical evidence for the treatment of pancreatic cyst is based on observational and retrospective studies.

Anonymous Patient Answer

What is pancreatic cyst?

Pancreatic cyst can be present all over the body, especially in the head of the pancreas and pancreatic duct (pancreatic head cyst). But, the pancreatic head cyst has a higher prevalence in developing countries, and the head of the pancreas cyst in developing countries is generally benign.

Anonymous Patient Answer

Is eus enhanced with contrast to evaluate pancreas typically used in combination with any other treatments?

Use of EUS with Gd-EOB or Gd-DTPA for imaging of the pancreas for the purposes of [image-guided radiotherapy (IGRT) or [selective internal radiation therapy (SIIT)]] typically given without any other treatments has a significant role in pre- or post-procedure treatment planning. EUS-IGRT or EUS-SIIT seems to be the preferable technique for imaging the pancreas for use in any form of pre- or post-procedure treatment planning or of [image-guided surgery].

Anonymous Patient Answer

Is eus enhanced with contrast to evaluate pancreas safe for people?

In this pilot study, contrast with eUS for the evaluation of pancreatic masses was safe and may be an alternative imaging modality when using MDCT.

Anonymous Patient Answer

What is eus enhanced with contrast to evaluate pancreas?

Contrast-enhanced CT is useful for evaluating pancreatitis both in acute and chronic form. EUS-guided aspiration may help to rule out malignant masses that might persist or regress after adequate treatment.

Anonymous Patient Answer

Does pancreatic cyst run in families?

Pancreatic cyst is a common disease affecting 1 in 1000 people from birth to age 60, but this number could increase with time. Considering the long period required for cyst onset, and the relatively benign course of the disease, most cysts remain asymptomatic, while some cause discomfort in the form of epigastric pain or intestinal obstruction. Families should be aware of a hereditary predisposition, when a personal or family history of pancreatic cysts or pancreatic cancer.

Anonymous Patient Answer

What is the latest research for pancreatic cyst?

The use of various imaging techniques during follow-up imaging is effective in the evaluation of pancreatic cysts and for predicting the prognosis of pancreatic cyst diseases. Further research is needed on the use of magnetic resonance imaging for predicting the recurrence of pancreatic cysts.

Anonymous Patient Answer

Has eus enhanced with contrast to evaluate pancreas proven to be more effective than a placebo?

Contrast-enhanced endoscopic ultrasonography with ultrasonography is an effective tool for achieving the diagnosis of pancreatic cysts, especially pancreatic cyst, and was proven to be more effective than a placebo treatment.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Pancreatic Cyst by sharing your contact details with the study coordinator.